CA2005281A1 - Tnf peptides - Google Patents

Tnf peptides

Info

Publication number
CA2005281A1
CA2005281A1 CA002005281A CA2005281A CA2005281A1 CA 2005281 A1 CA2005281 A1 CA 2005281A1 CA 002005281 A CA002005281 A CA 002005281A CA 2005281 A CA2005281 A CA 2005281A CA 2005281 A1 CA2005281 A1 CA 2005281A1
Authority
CA
Canada
Prior art keywords
asn
asp
peptide
gln
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002005281A
Other languages
English (en)
French (fr)
Inventor
Hans-Joachim Boehm
Bernhard Schmied
Lothar Daum
Andreas Haupt
Nigel Walker
Johann-Christian Zechel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of CA2005281A1 publication Critical patent/CA2005281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002005281A 1988-12-12 1989-12-12 Tnf peptides Abandoned CA2005281A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3841764.2 1988-12-12
DE3841764A DE3841764A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide

Publications (1)

Publication Number Publication Date
CA2005281A1 true CA2005281A1 (en) 1990-06-12

Family

ID=6368959

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005281A Abandoned CA2005281A1 (en) 1988-12-12 1989-12-12 Tnf peptides

Country Status (5)

Country Link
EP (1) EP0447472A1 (de)
JP (1) JPH04502155A (de)
CA (1) CA2005281A1 (de)
DE (1) DE3841764A1 (de)
WO (1) WO1990006941A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015044900A1 (en) * 2013-09-27 2015-04-02 Aurigene Discovery Technologies Limited Therapeutic immunomodulating compounds

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4340111A1 (de) * 1993-11-22 1995-05-24 Schering Ag Tumor-Nekrose-Faktor-alpha inaktivierende Peptide
PT769967E (pt) 1994-08-19 2008-02-18 Univ Catholique Louvain Conjugados que compreendem um agente antitumoral e a sua utilização

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU589919B2 (en) * 1984-10-15 1989-10-26 Cetus Corp Human tumor necrosis factor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015044900A1 (en) * 2013-09-27 2015-04-02 Aurigene Discovery Technologies Limited Therapeutic immunomodulating compounds

Also Published As

Publication number Publication date
DE3841764A1 (de) 1990-06-13
JPH04502155A (ja) 1992-04-16
EP0447472A1 (de) 1991-09-25
WO1990006941A1 (de) 1990-06-28

Similar Documents

Publication Publication Date Title
SI9300661A (en) Novel peptides with antineoplastic effect, the preparation and use thereof
NO326827B1 (no) Dolastatin 15 derivater, farmasoytiske preparater inneholdende slike forbindelser samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av kreft hos et pattedyr.
EP0642530B1 (de) Derivate des Dolastatin
CA2005058A1 (en) Tnf peptides
CA2005059A1 (en) Tnf peptides
CA2005050A1 (en) Tnf peptides
CA2005051A1 (en) Tnf peptides
CA2005060A1 (en) Tnf peptides
CA2005281A1 (en) Tnf peptides
CA2005061A1 (en) Tnf peptides
CA2005052A1 (en) Tnf peptides
CA2005057A1 (en) Tnf peptides
EP3647319A1 (de) Peptidverbindung, anwendung davon und zusammensetzung damit
CA2005056A1 (en) Tnf peptides
WO1992011285A1 (de) Neue tnf-peptide
DE4041189A1 (de) Neue-tnf-peptide

Legal Events

Date Code Title Description
FZDE Dead